U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519031) titled 'Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo' on April 01.
Brief Summary: This study evaluates whether exosomes derived from human umbilical cord mesenchymal stem cells (hUMSCs-Exo) are safe and effective for treating vitiligo in adults.
Vitiligo is a skin condition that causes white patches due to loss of pigment-producing cells. Current treatments have limitations, especially for patients with active disease who require oral steroids with significant side effects.
This study is a single-center, randomized, controlled trial enrolling 96 adults aged 18 to 65 years with non-segmental vitiligo. Partici...